Analysts expect Molina Healthcare, Inc. (NYSE:MOH) to post $4.66 billion in sales for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Molina Healthcare’s earnings, with the highest sales estimate coming in at $4.68 billion and the lowest estimate coming in at $4.63 billion. Molina Healthcare reported sales of $5.00 billion in the same quarter last year, which would indicate a negative year over year growth rate of 6.8%. The business is expected to announce its next earnings results on Wednesday, August 1st.

On average, analysts expect that Molina Healthcare will report full year sales of $18.71 billion for the current fiscal year, with estimates ranging from $18.59 billion to $18.79 billion. For the next year, analysts anticipate that the company will report sales of $16.76 billion per share, with estimates ranging from $16.48 billion to $17.31 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Molina Healthcare.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Monday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.90. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.74 billion. Molina Healthcare had a positive return on equity of 20.08% and a negative net margin of 2.46%. Molina Healthcare’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.63 earnings per share.

A number of analysts have recently issued reports on the company. Zacks Investment Research upgraded Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $113.00 price objective on the stock in a research report on Saturday, June 30th. JPMorgan Chase & Co. cut Molina Healthcare from an “overweight” rating to a “neutral” rating in a research report on Wednesday, June 27th. They noted that the move was a valuation call. Wells Fargo & Co boosted their price objective on Molina Healthcare from $90.00 to $92.00 and gave the company a “market perform” rating in a research report on Thursday, June 28th. BMO Capital Markets upped their price target on Molina Healthcare to $105.00 and gave the company a “market perform” rating in a research report on Tuesday, June 19th. Finally, Jefferies Financial Group upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, June 28th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $83.93.

In other news, Director Steven J. Orlando sold 1,500 shares of the stock in a transaction on Thursday, May 10th. The stock was sold at an average price of $82.10, for a total transaction of $123,150.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Garrey Carruthers sold 2,050 shares of the stock in a transaction on Thursday, June 7th. The stock was sold at an average price of $86.24, for a total value of $176,792.00. The disclosure for this sale can be found here. Insiders have sold 4,350 shares of company stock worth $369,716 in the last 90 days. Company insiders own 0.65% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Amundi Pioneer Asset Management Inc. bought a new stake in shares of Molina Healthcare during the fourth quarter worth $100,000. Eaton Vance Management bought a new stake in shares of Molina Healthcare during the first quarter worth $203,000. Pzena Investment Management LLC bought a new stake in shares of Molina Healthcare during the first quarter worth $251,000. Xact Kapitalforvaltning AB bought a new stake in shares of Molina Healthcare during the fourth quarter worth $310,000. Finally, PEAK6 Investments L.P. grew its holdings in shares of Molina Healthcare by 187.1% during the fourth quarter. PEAK6 Investments L.P. now owns 4,140 shares of the company’s stock worth $317,000 after purchasing an additional 2,698 shares during the last quarter.

MOH opened at $100.39 on Friday. The company has a market cap of $6.14 billion, a PE ratio of 179.27, a PEG ratio of 1.40 and a beta of 1.15. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.98. Molina Healthcare has a 1 year low of $56.67 and a 1 year high of $103.27.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.